{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:25:12Z","timestamp":1794086712013,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["regulation EU 2020 \/2094"],"award-info":[{"award-number":["regulation EU 2020 \/2094"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01 AI114685"],"award-info":[{"award-number":["2R01 AI114685"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1429567"],"award-info":[{"award-number":["CHE-1429567"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["BIO-199"],"award-info":[{"award-number":["BIO-199"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005508","name":"Boettcher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.antiviral.2026.106534","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:44:09Z","timestamp":1789515849000},"page":"106534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of 1,2-dihydroquinazolin-2-ones kinase inhibitors as anti-coronavirus agents"],"prefix":"10.1016","volume":"255","author":[{"given":"Blanca","family":"Mart\u00ednez-Arribas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2704","authenticated-orcid":false,"given":"Rosario","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenelle","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Walden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caden","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-5549","authenticated-orcid":false,"given":"Amy B.","family":"Dounay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-615X","authenticated-orcid":false,"given":"Mar\u00eda C.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Genilloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Ruiz-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-0439","authenticated-orcid":false,"given":"Marco","family":"Mottinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-0919","authenticated-orcid":false,"given":"Lori","family":"Ferrins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4303-5209","authenticated-orcid":false,"given":"Dolores","family":"Gonz\u00e1lez-Pacanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106534_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-4690-3-78","article-title":"Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription","volume":"3","author":"Ammosova","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.antiviral.2026.106534_bib2","doi-asserted-by":"crossref","first-page":"20154","DOI":"10.1021\/acs.jmedchem.5c01217","article-title":"Optimization of physicochemical properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines inhibitors of trypanosome proliferation","volume":"68","author":"Bachovchin","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28157","article-title":"Anti-SARS-CoV-2 activity of targeted kinase inhibitors: repurposing clinically available drugs for COVID-19 therapy","volume":"95","author":"Boytz","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106534_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/acsmedchemlett.2c00545","article-title":"A shift in thinking: cellular thermal shift assay-enabled drug discovery","volume":"14","author":"Caballero","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2026.106534_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/JVI.01705-06","article-title":"Suppression of coronavirus replication by inhibition of the MEK signaling pathway","volume":"81","author":"Cai","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106534_bib6","doi-asserted-by":"crossref","first-page":"27569","DOI":"10.18632\/oncotarget.15174","article-title":"Tat is a multifunctional viral protein that modulates cellular gene expression and functions","volume":"8","author":"Clark","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2026.106534_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003253","article-title":"Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign","volume":"8","author":"Diaz","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2026.106534_bib8","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.1021\/acs.jmedchem.4c00785","article-title":"Pharmacophore identification and structure-activity relationship analysis of a series of substituted azaindoles as inhibitors of Trypanosoma brucei","volume":"67","author":"Ferrins","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/2472555220973597","article-title":"CETSA MS profiling for a comparative assessment of FDA-approved antivirals repurposed for COVID-19 therapy identifies TRIP13 as a remdesivir off-target","volume":"26","author":"Friman","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.antiviral.2026.106534_bib10","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/acs.jproteome.3c00182","article-title":"Investigation of the host kinome response to coronavirus infection reveals PI3K\/mTOR inhibitors as betacoronavirus antivirals","volume":"22","author":"Fritch","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.antiviral.2026.106534_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108940","article-title":"Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication","volume":"35","author":"Garcia","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2026.106534_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v15020568","article-title":"Targeting human proteins for antiviral drug discovery and repurposing efforts: a focus on protein kinases","volume":"15","author":"Hajjo","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106534_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45687-y","article-title":"3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2\/c-Met-TK inhibitors: design, synthesis, and biological evaluation","volume":"13","author":"Hassan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106534_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106534_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02815-22","article-title":"The substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir","volume":"14","author":"Jochmans","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106534_bib17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/cmdc.201800178","article-title":"Identification of broad-spectrum Dengue\/Zika virus replication inhibitors by functionalization of quinoline and 2,6-Diaminopurine scaffolds","volume":"13","author":"Kaptein","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2026.106534_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1039\/D0MD00103A","article-title":"Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activity","volume":"11","author":"Klug","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib19","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1021\/acs.jmedchem.1c00674","article-title":"Lead optimization of 3,5-Disubstituted-7-Azaindoles for the treatment of human African trypanosomiasis","volume":"64","author":"Klug","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib20","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/acs.jmedchem.9b01506","article-title":"Hit-to-Lead optimization of benzoxazepinoindazoles as human African trypanosomiasis therapeutics","volume":"63","author":"Klug","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12967-020-02520-8","article-title":"Pathophysiology and treatment strategies for COVID-19","volume":"18","author":"Kumar","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.antiviral.2026.106534_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2026.106534_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2024.09.001","article-title":"SARS-CoV-2 NSP14 induces AP-1 transcriptional activity via its interaction with MEK","volume":"175","author":"Li","year":"2024","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2026.106534_bib24","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106534_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01679-23","article-title":"Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity","volume":"12","author":"Martinez-Arribas","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.antiviral.2026.106534_bib26","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/acs.chemrev.0c00648","article-title":"Drug design strategies to avoid resistance in direct-acting antivirals and beyond","volume":"121","author":"Matthew","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.antiviral.2026.106534_bib27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.24214","article-title":"c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication","volume":"53","author":"Pfannkuche","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106534_bib28","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.bmcl.2017.07.032","article-title":"2-dihydroquinazolin-2-ones: design, synthesis, and biological evaluation against Trypanosoma brucei","volume":"27","author":"Pham","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2026.106534_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108454","article-title":"Targeting conserved regions of the SARS-CoV-2 polymerase (RdRp) with kinase inhibitors as an effective new tactic for discovering dual-action \"antiviral-antiinflammatory\" drugs against COVID-19","volume":"119","author":"Rabie","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of kinase inhibitors as broad-spectrum antiviral drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.antiviral.2026.106534_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bioorg.2011.07.004","article-title":"Protein kinase biochemistry and drug discovery","volume":"39","author":"Schwartz","year":"2011","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib32","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/acs.jmedchem.0c01017","article-title":"Medicinal chemistry optimization of a diaminopurine chemotype: toward a lead for Trypanosoma brucei inhibitors","volume":"63","author":"Singh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13696","article-title":"Maribavir: mechanism of action, clinical, and translational science","volume":"17","author":"Sun","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.antiviral.2026.106534_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1074\/jbc.M703988200","article-title":"Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening","volume":"283","author":"Supekova","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/acs.jmedchem.9b01741","article-title":"Selectivity and physicochemical optimization of repurposed Pyrazolo[1,5-b]pyridazines for the treatment of human African trypanosomiasis","volume":"63","author":"Tear","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib36","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/acs.jmedchem.2c00444","article-title":"Development of azaindole-based frameworks as potential antiviral agents and their future perspectives","volume":"65","author":"Urvashi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106534_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113683","article-title":"System-oriented optimization of multi-target 2,6-diaminopurine derivatives: easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2","volume":"224","author":"Vicenti","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib39","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1021\/acs.jmedchem.5b00108","article-title":"Discovery of multitarget antivirals acting on both the Dengue Virus NS5-NS3 interaction and the host Src\/Fyn kinases","volume":"58","author":"Vincetti","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106534_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2026.106534_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2026.106534_bib42","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1016\/j.bmc.2015.08.006","article-title":"Kinase Hinge binding scaffolds and their hydrogen bond patterns","volume":"23","author":"Xing","year":"2015","journal-title":"Bioorg. Med. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:20:54Z","timestamp":1794086454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0166354226001932"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106534","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of 1,2-dihydroquinazolin-2-ones kinase inhibitors as anti-coronavirus agents","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106534"}}